Tesla, NIO And Some Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mixed, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

U.S. stocks traded mixed, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

  • WeWork Inc. (NASDAQ:WE) shares tumbled 15% to $1.11.
  • Satixfy Communications Ltd. (NYSE:SATX) fell 12.4% to $5.70.
  • Proterra Inc. (NASDAQ:PTRA) dropped 10.7% to $3.67. Proterra filed for mixed shelf of up to $500 million.
  • SIGNA Sports United N.V. (NYSE:SSU) fell 10.6% to $3.37.
  • Nutex Health Inc. (NASDAQ:NUTX) dropped 10.3% to $1.8650. Benchmark recently initiated coverage on Nutex Health with a Buy rating and announced a price target of $3.
  • Velo3D, Inc. (NYSE:VLD) fell 9.7% to $1.7050.
  • Sonder Holdings Inc. (NASDAQ:SOND) dropped 9.7% to $1.2550.
  • Companhia Brasileira de Distribuição (NYSE:CBD) fell 9.5% to $3.1389.
  • Coherus BioSciences, Inc. (NASDAQ:CHRS) dipped 9.2% to $5.86. Junshi Biosciences and Coherus said that FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA for Toripalimab as treatment for recurrent or metastatic nasopharyngeal carcinoma.
  • Tesla, Inc. (NASDAQ:TSLA) dropped 8.5% to $112.71. Reports suggested the company preponed plans regarding the shutdown of its Giga Shanghai plant. Also, Chinese competitor Nio reduced its Q4 delivery guidance, which could also be negatively impacting Tesla’s price action.
  • NIO Inc. (NYSE:NIO) fell 8.2% to $10.07 after the company lowered its Q4 deliveries guidance.
  • Solid Power, Inc. (NASDAQ:SLDP) fell 8% to $2.30. Solid Power recently announced it has deepened its partnership with the BMW Group. Solid Power granted the BMW Group a research and development license to its all-solid-state cell design and manufacturing know-how.
  • AMC Entertainment Holdings, Inc. (NYSE:AMC) dropped 6.4% to $4.1172 after dropping 10% on Friday. AMC recently announced a $110 million equity capital raise.

Also Check This Out Ethereum Falls But Remains Above $1,200; Terra Classic, Quant Among Top Gainers

Total
0
Shares
Related Posts
Read More

Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY

Cannabinoids-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) reported on Tuesday year-end 2023 results and audited financial statements. The Canadian company reported CA$16.8 million ($12.3 million) in total revenue, up by 314% year-over-year. Avicanna mostly attributed a surge in revenue to the acquisition of Medical Cannabis by Shoppers from Shoppers Drug Mart and the launch of MyMedi.ca. "2023 was a tremendous year for Avicanna where we solidified our leadership position in the Canadian medical cannabis sector through our proprietary products and the launch of MyMedi.ca," he said. "We have successfully demonstrated the scalability of our revenues and made significant improvements in our fundamentals while advancing all our business pillars."

AVCNF